Literature DB >> 2420943

Ultrastructural features of the lymphocyte-stimulated halos produced by human glioma-derived cells in vitro.

M A Oberc-Greenwood, L M Muul, M K Gately, P L Kornblith, B H Smith.   

Abstract

Many glioma-derived cell lines have the capability of escaping cell-mediated immune attack. One mechanism of escape is the secretion of a hyaluronidase-sensitive mucopolysaccharide coat by these cells. This coat prevents contact and tumor cell killing by specific cytolytic allogeneic lymphocytes. The production of the coat by the tumor cells is stimulated by a macromolecular factor released by peripheral blood mononuclear (PBMC) cells in culture. We have examined the morphologic and ultrastructural features of this extracellular matrix. Three coat-producing lines were studied. Under phase contrast light microscopy, the coat is a clear pericellular 'halo'. To stain this zone, ruthenium red and Alcian Blue 8 G stains, which bind to acid mucopolysaccharides (to a large extent, hyaluronic acid), were used. The two stains produced similar results. With light microscopy, a weblike pattern of stain was evident throughout the halo region. With transmission electron microscopy, staining was found along the plasma membrane of the glioma cells and their microvilli, stretching in long, branching filaments from these surfaces and, in some instances, from one microvillus to the next. Since mucopolysaccharide matrices have a large aqueous component, it was necessary to determine whether dehydration alters the stain pattern. Therefore, undehydrated ruthenium red stained specimens from each culture were embedded in Quetal 651 (Ted Pella, Inc., Tustin, CA), a water soluble plastic. No morphologic differences were noted between the hydrated and dehydrated specimens. This study indicates that numerous long microvilli and a secreted mucopolysaccharide matrix are important structural elements of the lymphocyte-stimulated tumor cell halo in vitro. The mechanism by which the PBMC factor stimulates coat formation and the importance of the coat in in vivo tumor defenses remain to be elucidated.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2420943     DOI: 10.1007/bf00165589

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  28 in total

1.  The partition of solutes between buffer solutions and solutions containing hyaluronic acid.

Authors:  A G OGSTON; C F PHELPS
Journal:  Biochem J       Date:  1961-04       Impact factor: 3.857

2.  Fibrin in human tumors.

Authors:  R HIRAMOTO; J BERNECKY; J JURANDOWSKI; D PRESSMAN
Journal:  Cancer Res       Date:  1960-06       Impact factor: 12.701

3.  Ruthenium red and violet. I. Chemistry, purification, methods of use for electron microscopy and mechanism of action.

Authors:  J H Luft
Journal:  Anat Rec       Date:  1971-11

4.  Ultrastructural and histochemical observations of optic nerve gliomas.

Authors:  D R Anderson; W H Spencer
Journal:  Arch Ophthalmol       Date:  1970-03

5.  Fibrin gel investment associated with line 1 and line 10 solid tumor growth, angiogenesis, and fibroplasia in guinea pigs. Role of cellular immunity, myofibroblasts, microvascular damage, and infarction in line 1 tumor regression.

Authors:  H F Dvorak; A M Dvorak; E J Manseau; L Wiberg; W H Churchill
Journal:  J Natl Cancer Inst       Date:  1979-06       Impact factor: 13.506

6.  In vitro studies on the cell-mediated immune response to human brain tumors. II. Leukocyte-induced coats of glycosaminoglycan increase the resistance of glioma cells to cellular immune attack.

Authors:  C L Gately; L M Muul; M A Greenwood; S Papazoglou; S J Dick; P L Kornblith; B H Smith; M K Gately
Journal:  J Immunol       Date:  1984-12       Impact factor: 5.422

7.  Glycosaminoglycan synthesis by cultured human skin fibroblasts after transformation with simian virus 40.

Authors:  J J Hopwood; A Dorfman
Journal:  J Biol Chem       Date:  1977-07-25       Impact factor: 5.157

8.  In vitro studies on the cell-mediated immune response to human brain tumors. I. Requirement for third-party stimulator lymphocytes in the induction of cell-mediated cytotoxic responses to allogeneic cultured gliomas.

Authors:  M K Gately; M Glaser; S J Dick; R W Mettetal; P L Kornblith
Journal:  J Natl Cancer Inst       Date:  1982-12       Impact factor: 13.506

9.  Detection of glycosaminoglycans in human gliomas by histochemical methods.

Authors:  P Böck; K Jellinger
Journal:  Acta Neuropathol Suppl       Date:  1981

10.  Hyaluronidase-sensitive halos around adherent cells. Their role in blocking lymphocyte-mediated cytolysis.

Authors:  W H McBride; J B Bard
Journal:  J Exp Med       Date:  1979-02-01       Impact factor: 14.307

View more
  6 in total

1.  Mechanisms of malignant glioma immune resistance and sources of immunosuppression.

Authors:  German G Gomez; Carol A Kruse
Journal:  Gene Ther Mol Biol       Date:  2006

2.  Selective cytoplasmic and membrane changes induced by cisplatinum.

Authors:  M A Oberc-Greenwood; B H Smith; C Cooke; C Pepin; P L Kornblith
Journal:  J Neurooncol       Date:  1990-12       Impact factor: 4.130

3.  Cellular and functional characterization of immunoresistant human glioma cell clones selected with alloreactive cytotoxic T lymphocytes reveals their up-regulated synthesis of biologically active TGF-beta.

Authors:  German G Gomez; Carol A Kruse
Journal:  J Immunother       Date:  2007-04       Impact factor: 4.456

4.  Cellular cancer vaccines: an update on the development of vaccines generated from cell surface antigens.

Authors:  Petr G Lokhov; Elena E Balashova
Journal:  J Cancer       Date:  2010-11-29       Impact factor: 4.207

Review 5.  Glycomaterials to Investigate the Functional Role of Aberrant Glycosylation in Glioblastoma.

Authors:  Chaitanya Tondepu; Lohitash Karumbaiah
Journal:  Adv Healthc Mater       Date:  2021-12-29       Impact factor: 11.092

Review 6.  The scrambled story between hyaluronan and glioblastoma.

Authors:  Matías Arturo Pibuel; Daniela Poodts; Mariángeles Díaz; Silvia Elvira Hajos; Silvina Laura Lompardía
Journal:  J Biol Chem       Date:  2021-03-17       Impact factor: 5.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.